President Trump has signed an executive order to ease research restrictions on psychedelics, including the drug ibogaine, which is used in some countries to treat post-traumatic stress disorder.

April 20 (Reuters) - Shares of psychedelic drug developers rose on Monday after U.S. President Donald Trump signed an executive order directing health regulators to speed up reviews ‌of psychedelic ...

President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs." "The ...

President Trump struggles to make a plan for artificial intelligence regulation after initially taking a hands off position on the emerging technology.

A psychedelic used in some countries to treat post-traumatic stress disorder is expected to get a closer examination from the federal government on its safety and effectiveness, sources told CBS News.

President Donald Trump will sign two executive orders Monday to try to lower beef prices, according to a White House official, the latest effort by the administration to counter high consumer prices ...

The president said he postponed the executive order, which would give the government power to evaluate A.I. models before ...

President Donald Trump is reportedly planning to sign a new executive order that will increase research into psychedelic drugs used to treat mental illnesses, potentially paving the way for their ...